125 related articles for article (PubMed ID: 38124547)
1. Noncanonical CALR variants.
Langabeer SE
Am J Clin Pathol; 2024 May; 161(5):519. PubMed ID: 38124547
[No Abstract] [Full Text] [Related]
2. Reply to "Noncanonical CALR variants".
Krishnamurthy K
Am J Clin Pathol; 2024 May; 161(5):520. PubMed ID: 38124540
[No Abstract] [Full Text] [Related]
3. Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.
Pietra D; Rumi E; Ferretti VV; Di Buduo CA; Milanesi C; Cavalloni C; Sant'Antonio E; Abbonante V; Moccia F; Casetti IC; Bellini M; Renna MC; Roncoroni E; Fugazza E; Astori C; Boveri E; Rosti V; Barosi G; Balduini A; Cazzola M
Leukemia; 2016 Feb; 30(2):431-8. PubMed ID: 26449662
[TBL] [Abstract][Full Text] [Related]
4. Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasms.
Mózes R; Gángó A; Sulák A; Vida L; Reiniger L; Timár B; Krenács T; Alizadeh H; Masszi T; Gaál-Weisinger J; Demeter J; Csomor J; Matolcsy A; Kajtár B; Bödör C
Pathology; 2019 Apr; 51(3):301-307. PubMed ID: 30606612
[TBL] [Abstract][Full Text] [Related]
5. [Development of myeloproliferative neoplasms by mutant calreticulin: underlying mechanisms].
Araki M
Rinsho Ketsueki; 2018; 59(8):1072-1077. PubMed ID: 30185708
[TBL] [Abstract][Full Text] [Related]
6. Mutant specific anti calreticulin antibody (CAL2) immunohistochemistry as a screening test for calreticulin (CALR) mutation testing.
Rahman K; Chandra D; Singh MK; Gupta R; Sharma A; Paul P; Kumar S; Sharma S; Nityanand S
Int J Lab Hematol; 2020 Oct; 42(5):604-611. PubMed ID: 32463176
[TBL] [Abstract][Full Text] [Related]
7. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.
Nangalia J; Massie CE; Baxter EJ; Nice FL; Gundem G; Wedge DC; Avezov E; Li J; Kollmann K; Kent DG; Aziz A; Godfrey AL; Hinton J; Martincorena I; Van Loo P; Jones AV; Guglielmelli P; Tarpey P; Harding HP; Fitzpatrick JD; Goudie CT; Ortmann CA; Loughran SJ; Raine K; Jones DR; Butler AP; Teague JW; O'Meara S; McLaren S; Bianchi M; Silber Y; Dimitropoulou D; Bloxham D; Mudie L; Maddison M; Robinson B; Keohane C; Maclean C; Hill K; Orchard K; Tauro S; Du MQ; Greaves M; Bowen D; Huntly BJP; Harrison CN; Cross NCP; Ron D; Vannucchi AM; Papaemmanuil E; Campbell PJ; Green AR
N Engl J Med; 2013 Dec; 369(25):2391-2405. PubMed ID: 24325359
[TBL] [Abstract][Full Text] [Related]
8. Secreted calreticulin mutants subvert anticancer immunosurveillance.
Liu P; Zhao L; Kroemer G; Kepp O
Oncoimmunology; 2020; 9(1):1708126. PubMed ID: 32002304
[TBL] [Abstract][Full Text] [Related]
9. Frequency of Calreticulin (CALR) Mutation and Its Clinical Prognostic Significance in Essential Thrombocythemia and Primary Myelofibrosis: A Meta-analysis.
Kong H; Liu Y; Luo S; Li Q; Wang Q
Intern Med; 2016; 55(15):1977-84. PubMed ID: 27477402
[TBL] [Abstract][Full Text] [Related]
10. Possible Roles of Calreticulin in Uterine Decidualization and Receptivity in Rats and Humans.
Yoshie M; Kusama K; Tanaka R; Okubo T; Kojima J; Takaesu Y; Isaka K; Nishi H; Tamura K
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638846
[TBL] [Abstract][Full Text] [Related]
11. Mutant calreticulin interacts with MPL in the secretion pathway for activation on the cell surface.
Masubuchi N; Araki M; Yang Y; Hayashi E; Imai M; Edahiro Y; Hironaka Y; Mizukami Y; Kihara Y; Takei H; Nudejima M; Koike M; Ohsaka A; Komatsu N
Leukemia; 2020 Feb; 34(2):499-509. PubMed ID: 31462733
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous screening for JAK2 and calreticulin gene mutations in myeloproliferative neoplasms with high resolution melting.
Matsumoto N; Mori S; Hasegawa H; Sasaki D; Mori H; Tsuruda K; Imanishi D; Imaizumi Y; Hata T; Kaku N; Kosai K; Uno N; Miyazaki Y; Yanagihara K
Clin Chim Acta; 2016 Nov; 462():166-173. PubMed ID: 27693531
[TBL] [Abstract][Full Text] [Related]
13. Diversities of Calreticulin Gene Mutations in Macedonian Patients With Essential Thrombocythemia.
Panovska-Stavridis I; Eftimov A; Ivanovski M; Stojanovic A; Georgievski B; Cevreska L; Dimovski AJ
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):477-81. PubMed ID: 27521277
[TBL] [Abstract][Full Text] [Related]
14. Calreticulin-mutant proteins induce megakaryocytic signaling to transform hematopoietic cells and undergo accelerated degradation and Golgi-mediated secretion.
Han L; Schubert C; Köhler J; Schemionek M; Isfort S; Brümmendorf TH; Koschmieder S; Chatain N
J Hematol Oncol; 2016 May; 9(1):45. PubMed ID: 27177927
[TBL] [Abstract][Full Text] [Related]
15. Myeloproliferative Neoplasms With Calreticulin Mutations Exhibit Distinctive Morphologic Features.
Loghavi S; Bueso-Ramos CE; Kanagal-Shamanna R; Ok CY; Salim AA; Routbort MJ; Mehrotra M; Verstovsek S; Medeiros LJ; Luthra R; Patel KP
Am J Clin Pathol; 2016 Mar; 145(3):418-27. PubMed ID: 27124925
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of calreticulin exon 9 indel mutations in vascular risk patients.
Jaeger T; Muendlein A; Hodaie J; Untergasser G; Steurer M; Saely CH; Drexel H; Lang AH
Thromb Res; 2016 Aug; 144():215-7. PubMed ID: 27423004
[TBL] [Abstract][Full Text] [Related]
17. The Mutation Profile of Calreticulin in Patients with Myeloproliferative Neoplasms and Acute Leukemia.
Wang J; Hao J; He N; Ji C; Ma D
Turk J Haematol; 2016 Sep; 33(3):180-6. PubMed ID: 26377485
[TBL] [Abstract][Full Text] [Related]
18. Defining the requirements for the pathogenic interaction between mutant calreticulin and MPL in MPN.
Elf S; Abdelfattah NS; Baral AJ; Beeson D; Rivera JF; Ko A; Florescu N; Birrane G; Chen E; Mullally A
Blood; 2018 Feb; 131(7):782-786. PubMed ID: 29288169
[TBL] [Abstract][Full Text] [Related]
19. Mutation specific immunohistochemistry is highly specific for the presence of calreticulin mutations in myeloproliferative neoplasms.
Andrici J; Farzin M; Clarkson A; Sioson L; Sheen A; Watson N; Toon CW; Koleth M; Stevenson W; Gill AJ
Pathology; 2016 Jun; 48(4):319-24. PubMed ID: 27114372
[TBL] [Abstract][Full Text] [Related]
20. Calreticulin (CALR) promotes ionophore-induced microneme secretion in Toxoplasma gondii.
Shan Z; Song X; Yang X; Xue Y; Wu Y; Wang X; Liu J; Liu Q
Parasitol Res; 2024 Feb; 123(2):139. PubMed ID: 38381180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
